T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A8.1 KBTobira Therapeutics, Inc.Feb 14, 12:08 PM ET·0000315066-17-002077
- SC 13G/A158.9 KBTobira Therapeutics, Inc.Jan 18, 2:25 PM ET·0001104659-17-002759
- SC 13D/A94.6 KBTobira Therapeutics, Inc.Nov 4, 4:49 PM ET·0000904454-16-001545
- 421.2 KBTobira Therapeutics, Inc.Nov 4, 8:30 AM ET·0000904454-16-001535
- 411.0 KBTobira Therapeutics, Inc.Nov 3, 9:54 PM ET·0000904454-16-001533
- 412.2 KBTobira Therapeutics, Inc.Nov 3, 9:47 PM ET·0000904454-16-001531
- 412.1 KBTobira Therapeutics, Inc.Nov 3, 9:45 PM ET·0000904454-16-001529
- 411.0 KBTobira Therapeutics, Inc.Nov 3, 9:42 PM ET·0000904454-16-001527
- 44.9 KBTobira Therapeutics, Inc.Nov 3, 5:26 PM ET·0001012975-16-001554
- SC 13D/A40.4 KBTobira Therapeutics, Inc.Nov 3, 5:24 PM ET·0001193125-16-759083
Insiders
10- Allergan plc10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- BLAIR JAMES C10% Owner
- Brosgart Carol LDirector
- BVF INC/ILSee Explanation of Responses
- BVF PARTNERS L P/ILSee Explanation of Responses
- Clark B. JeffersonDirector
- Cooper Jeffrey HDirector
- DOMAIN ASSOCIATES10% Owner
- DOMAIN PARTERS VII L P10% Owner
Tickers
No tickers on record
Addresses
business
701 GATEWAY BLVD SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
701 GATEWAY BLVD SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Tibira Therapeutics, Inc.2015-05-06
- Regado Biosciences Inc2015-05-06